Hydrophobic benzoic acids as inhibitors of influenza neuraminidase

被引：38

作者：

Atigadda, VR

Brouillette, WJ ^{[1
]}

Duarte, F

Babu, YS

Bantia, S

Chand, P

Chu, NM

Montgomery, JA

Walsh, DA

Sudbeck, E

Finley, J

Air, GM

Luo, M

Laver, GW

机构：

[1] Univ Alabama, Dept Chem, Birmingham, AL 35294 USA

[2] Univ Alabama, Ctr Macromol Crystallog, Birmingham, AL 35294 USA

[3] BioCryst Pharmaceut Inc, Birmingham, AL 35244 USA

[4] Univ Oklahoma, Dept Biochem & Mol Biol, Oklahoma City, OK 73190 USA

[5] Australian Natl Univ, John Curtin Sch Med Res, Canberra, ACT 2601, Australia

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 1999年 / 7卷 / 11期

关键词：

neuraminidase; influenza virus; sialidase; structure-based drug design;

D O I：

10.1016/S0968-0896(99)00197-2

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Neuraminidase (NA) plays a critical role in the life cycle of influenza virus and is a target for new therapeutic agents. A new benzoic acid inhibitor (11) containing a lipophilic side chain at C-3 and a guanidine at C-5 was synthesized. The X-ray structure of 4-(N-acetylamino)-5-guanidino-3-(3-pentyloxy)benzoic acid in complex with NA revealed that the lipophilic side chain binds in a newly created hydrophobic pocket formed by the movement of Glu 278 to interact with Arg 226, whereas the guanidine of 11 interacts In a negatively charged pocket created by Asp 152, Glu 120 and Glu 229. Compound 11 was highly selective for type A (H2N2) influenza NA (IC50 1 mu M) over type B (B/Lee/40) influenza NA (IC50 500 mu M). (C) 1999 Elsevier Science Ltd. All rights reserved.

引用

页码：2487 / 2497

页数：11

共 50 条

[41] Peramivir Phosphonate Derivatives as Influenza Neuraminidase Inhibitors
Wang, Peng-Cheng
Fang, Jim-Min
Tsai, Keng-Chang
Wang, Shi-Yun
Huang, Wen-I
Tseng, Yin-Chen
Cheng, Yih-Shyun E.
Cheng, Ting-Jen Rachel
Wong, Chi-Huey
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (11) : 5297 - 5310
[42] Neuraminidase inhibitors take bite out of influenza
Vicki Glaser
Nature Biotechnology, 1998, 16 : 1002 - 1002
[43] Treating influenza with neuraminidase inhibitors: an update of the literature
Bassetti, Matteo
Sepulcri, Chiara
Giacobbe, Daniele Roberto
Fusco, Ludovica
EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (09) : 1163 - 1174
[44] Exploring the chemical space of influenza neuraminidase inhibitors
Anuwongcharoen, Nuttapat
Shoombuatong, Watshara
Tantimongcolwat, Tanawut
Prachayasittikul, Virapong
Nantasenamat, Chanin
PEERJ, 2016, 4
[45] Combating influenza: natural products as neuraminidase inhibitors
Nisha Singh
Nawed Anjum
Ramesh Chandra
Phytochemistry Reviews, 2019, 18 : 69 - 107
[46] Design of aromatic inhibitors of influenza virus neuraminidase
Luo, M
Air, GM
Brouillette, WJ
OPTIONS FOR THE CONTROL OF INFLUENZA III, 1996, 1123 : 702 - 712
[47] Terephthalic acid derivatives - Inhibitors of influenza neuraminidase
Babu, YS
Chand, P
Walsh, DA
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1996, 211 : 237 - ORGN
[48] Should Neuraminidase Inhibitors Be Prescribed for Patients With Influenza?
Patel, Deepa M.
Pitts, Stephen R.
Hargraves, Joshua
ANNALS OF EMERGENCY MEDICINE, 2014, 63 (01) : 54 - 55
[49] Systematic review of influenza resistance to the neuraminidase inhibitors
Thorlund, Kristian
Awad, Tahany
Boivin, Guy
Thabane, Lehana
BMC INFECTIOUS DISEASES, 2011, 11
[50] Neuraminidase inhibitors for preventing and treating influenza in children
Matheson, N. J.
Harnden, A. R.
Perera, R.
Sheikh, A.
Symmonds-Abrahams, M.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2007, (01):

← 1 2 3 4 5 →